Aligos Therapeutics, Inc. (ALGS) AI Dilution Summary

Cash was $30,381,000 at 2026-06-30 against estimated monthly burn of $8,316,667. After that date, the company received a $25,000,000 net upfront licence payment from Xiamen Amoytop Biotech in July 2026. That payment is non-dilutive.